Publications/ Presentations

Adnexus creates novel medicines using a proprietary class of biologics called Adnectins™. Please use this presentations & publications section to obtain further details on our Adnectin class, PROfusion protein engine, and the medicines we aim to create.

2008 ASCO Oral Presentation on CT-322 in Phase 1
click on link to download pdf

2009 AACR Poster on EGFR - IGF1R Bispecific Adnectin
click on link to download pdf

2009 AACR Poster on CT-322 + temozolomide
click on link to download pdf

2010 AACR Poster on EGFR-IGF1R Bispecific Adnectin
click on link to download pdf

2010 ASCO Poster on Interim Results of a Phase 2 Study on CT-322
click on link to download pdf

2010 Publication on CT-322 in the journal MAbs
click on link to view the abstract

Where are we speaking?

In 2008, we delivered an oral presentation at ASCO discussing the Phase 1 data for CT-322, our lead Adnectin candidate.